{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:02:14Z","timestamp":1760547734805},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2004,5,3]],"date-time":"2004-05-03T00:00:00Z","timestamp":1083542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,5,3]],"date-time":"2004-05-03T00:00:00Z","timestamp":1083542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,6,1]]},"DOI":"10.1038\/sj.bmt.1704473","type":"journal-article","created":{"date-parts":[[2004,5,3]],"date-time":"2004-05-03T09:09:34Z","timestamp":1083575374000},"page":"1219-1224","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation"],"prefix":"10.1038","volume":"33","author":[{"given":"M L","family":"Donato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R E","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J T","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T W","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D C","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M W","family":"Bevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C F","family":"Levenback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"R C","family":"Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R S","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Ippoliti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Gajewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D M","family":"Gershenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,5,3]]},"reference":[{"key":"BF1704473_CR1","first-page":"30","volume":"93","author":"KA Oriel","year":"1999","unstructured":"Oriel KA, Hartenbach EM, Remington PL . Trends in United States ovarian cancer mortality, 1979\u20131995. Obstet Gynecol 1999; 93: 30\u201333.","journal-title":"Obstet Gynecol"},{"issue":"Suppl. 12","key":"BF1704473_CR2","first-page":"1","volume":"98","author":"A Hanai","year":"1990","unstructured":"Hanai A . Trends and differentials in ovarian cancer: incidence, mortality and survival experience. APMIS 1990; 98 (Suppl. 12): 1\u201320.","journal-title":"APMIS"},{"issue":"Suppl. 2","key":"BF1704473_CR3","first-page":"517","volume":"71","author":"R Yancik","year":"1993","unstructured":"Yancik R . Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 1993; 71 (Suppl. 2): 517\u2013523.","journal-title":"Cancer"},{"key":"BF1704473_CR4","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1200\/JCO.1998.16.7.2426","volume":"16","author":"M Gore","year":"1998","unstructured":"Gore M, Mainwaring P, A'Hern R et al. Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol 1998; 16: 2426\u20132434.","journal-title":"J Clin Oncol"},{"key":"BF1704473_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/sj.bmt.1702421","volume":"25","author":"ML Donato","year":"2000","unstructured":"Donato ML, Gershenson D, Ippoliti C et al. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant 2000; 25: 1137\u20131140.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704473_CR6","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 1748\u20131756.","journal-title":"J Clin Oncol"},{"key":"BF1704473_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1006\/gyno.2001.6326","volume":"82","author":"ML Donato","year":"2001","unstructured":"Donato ML, Gershenson DM, Wharton JT et al. High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol 2001; 82: 420\u2013426.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","volume":"14","author":"GJ Rustin","year":"1996","unstructured":"Rustin GJ, Nelstrop AE, McClean P et al. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol 1996; 14: 1545\u20131551.","journal-title":"J Clin Oncol"},{"key":"BF1704473_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1054\/bjoc.2001.2030","volume":"85","author":"TG Clark","year":"2001","unstructured":"Clark TG, Stewart ME, Altman DG, Gabra H, Smyth JF . A prognostic model for ovarian cancer. Br J Cancer 2001; 85: 944\u2013952.","journal-title":"Br J Cancer"},{"key":"BF1704473_CR10","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000; 88: 2584\u20132589.","journal-title":"Cancer"},{"key":"BF1704473_CR11","first-page":"438","volume":"19","author":"J Tammela","year":"1998","unstructured":"Tammela J, Geisler JP, Eskew Jr PN, Geisler HE . Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma. Eur J Gynaecol Oncol 1998; 19: 438\u2013440.","journal-title":"Eur J Gynaecol Oncol"},{"key":"BF1704473_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/gyno.2001.6382","volume":"83","author":"M Eren","year":"2001","unstructured":"Eren M, Rakar S, Klanar B, Syrj\u00e4nen K . Endometriosis-associated ovarian carcinoma (EAOC): an entity district from other ovarian carcinomas as suggested by a nested case\u2013control study. Gynecol Oncol 2001; 83: 100\u2013108.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.7326\/0003-4819-133-7-200010030-00009","volume":"133","author":"PJ Stiff","year":"2000","unstructured":"Stiff PJ, Veum-Stone J, Lazarus HM et al. High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an Autologous Blood and Marrow Transplant Registry Report. Ann Intern Med 2000; 133: 504\u2013515.","journal-title":"Ann Intern Med"},{"key":"BF1704473_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1200\/JCO.2002.20.3.694","volume":"20","author":"RR Barakat","year":"2002","unstructured":"Barakat RR, Sabbatini P, Bhaskaran D et al. Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol 2002; 20: 694\u2013698.","journal-title":"J Clin Oncol"},{"key":"BF1704473_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/gyno.2001.6363","volume":"83","author":"C Tournigand","year":"2001","unstructured":"Tournigand C, Louvet C, Molitor JL et al. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma. Gynecol Oncol 2001; 83: 198\u2013204.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/gyno.1999.5541","volume":"75","author":"A MacGibbon","year":"1999","unstructured":"MacGibbon A, Bucci J, MacLeod C et al. Whole abdominal radiotherapy following second-look laparotomy for ovarian cancer. Gynecol Oncol 1999; 75: 62\u201367.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/gyno.1998.5184","volume":"72","author":"H Pickel","year":"1999","unstructured":"Pickel H, Lahousen M, Petru E et al. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol 1999; 72: 215\u2013219.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1006\/gyno.1997.4696","volume":"65","author":"AJ Cmelak","year":"1997","unstructured":"Cmelak AJ, Kapp DS . Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer. Gynecol Oncol 1997; 65: 453\u2013460.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1023\/A:1008256431090","volume":"8","author":"ME Lambert","year":"1997","unstructured":"Lambert ME, Rustin GJ, Gregory WM, Nelstrop AE . A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study. Ann Oncol 1997; 8: 327\u2013333.","journal-title":"Ann Oncol"},{"key":"BF1704473_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0090-8258(92)90305-3","volume":"45","author":"TB Hakes","year":"1992","unstructured":"Hakes TB, Chalas E, Hoskins WJ et al. Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma. Gynecol Oncol 1992; 45: 284\u2013289.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/gyno.1999.5532","volume":"75","author":"JS Berek","year":"1999","unstructured":"Berek JS, Markman M, Stonebraker B et al. Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group. Gynecol Oncol 1999; 75: 10\u201314.","journal-title":"Gynecol Oncol"},{"key":"BF1704473_CR22","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1200\/JCO.2001.19.14.3422","volume":"19","author":"GN Hortobagyi","year":"2001","unstructured":"Hortobagyi GN, Ueno NT, Xia W et al. Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I trial. J Clin Oncol 2001; 19: 3422\u20133433.","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"BF1704473_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1525-1438.2000.99512.x","volume":"10","author":"JA Ledermann","year":"2000","unstructured":"Ledermann JA . High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer. Int J Gynecol Cancer 2000; 10 (Suppl. 1): 53\u201356.","journal-title":"Int J Gynecol Cancer"},{"key":"BF1704473_CR24","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1200\/JCO.1997.15.4.1302","volume":"15","author":"M Legros","year":"1997","unstructured":"Legros M, Dauplat S, Fleury J et al. High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol 1997; 15: 1302\u20131308.","journal-title":"J Clin Oncol"},{"key":"BF1704473_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1200\/JCO.1997.15.4.1309","volume":"15","author":"PJ Stiff","year":"1997","unstructured":"Stiff PJ, Bayer R, Kerger C et al. High-dose chemotherapy with autologous transplantation for persistent\/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. J Clin Oncol 1997; 15: 1309\u20131317.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704473","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:53:41Z","timestamp":1648079621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,3]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,6,1]]}},"alternative-id":["BF1704473"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704473","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,3]]},"assertion":[{"value":"15 April 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}